MedTrace Logo

Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement

NCT05696210 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2023-01-25

No results posted yet for this study

Summary

The primary objective of this work is to study the 1-year prognosis of patients who received Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock with the need for blood transfusion. Secondary objectives are to determine whether the transfusion strategy used (liberal or restrictive) still has an impact on overall mortality. We will also determine the factors associated with overall in-hospital mortality and look at the impact of transfusion in relation to the risk of hemolysis on the consequences in the occurrence of long-term chronic renal failure.

Conditions

  • Extracorporeal Membrane Oxygenation Complication
  • Blood Cells Transfusion
  • Transfusion Related Complication

Interventions

OTHER

Transfusion rate of red blood cells

Transfusion rate of red blood cells greater than 7

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-20
Primary Completion
2023-01-21
Completion
2023-03-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05696210 on ClinicalTrials.gov